Atlas Trials

A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection

Clinical trial NCT04544215 · SUSPENDED

Trial details

NCT number
NCT04544215
Sponsor
Ruijin Hospital
Status
SUSPENDED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Drug-resistant
Start date
2020-07-01
Primary completion
2024-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.